INMB: the cash flow

MyFinsight

Cash Flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Net loss	-5,407	-5,264	-6,472	-34,197
Stock-based compensation	1,497	3,316	2,984	3,610
Accretion of debt discount	NaN	0	NaN	NaN
Gain on settlement of accounts payable	-91	-1,252	626	NaN
Depreciation expense	52	56	28	NaN
Deferred liabilities	NaN	0	-511	-6
Impairment of acquired in-process research and development intangible assets	NaN	0	0	16,514
Research and development tax credit receivable	-3,805	2,580	99	424
Other tax receivable	34	-503	210	322
Accretion of debt discount	NaN	NaN	NaN	0
Prepaid expenses	99	123	-33	174
Prepaid expenses related party	NaN	0	NaN	0
Accounts payable and accrued liabilities related parties	NaN	NaN	NaN	159
Other assets	88	-151	176	491
Accounts payable and accrued liabilities	-3,018	893	-170	1,132
Operating lease liabilities	-20	104	-61	NaN
Net cash used in operating activities	-3,403	-2,944	-5,439	-14,199
Purchase of fixed assets	NaN	143	193	706
Net cash used in investing activities	NaN	-143	-193	-706
Net proceeds from sale of common stock and warrants	NaN	0	0	27,544
Repayments of debt	NaN	NaN	NaN	0
Cash proceeds for amendment of warrants	NaN	67	NaN	NaN
Exercise of warrants for cash	NaN	0	0	1
Net cash provided by financing activities	NaN	67	0	27,545
Impact on cash from foreign currency translation	10	37	-8	-188
Net decrease in cash and cash equivalents	-3,393	-2,983	-5,640	12,452
Cash and cash equivalents at beginning of period	24,751	27,734	20,922	NaN
Cash and cash equivalents at end of period	21,358	24,751	27,734	NaN

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.